3 Warren Buffett Stocks to Buy in 2026 and Hold Forever

Legendary investor Warren Buffett is no longer the CEO of Berkshire Hathaway, but his investing methods and advice will live ...

Artisan Partners Mid Cap Value Fund’s Q3 2025 Investor Letter

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” third-quarter 2025 investor ...

SGA Global Growth Strategy’s Q3 2025 Investor Letter

Sustainable Growth Advisers (SGA), an investment management company, released its third-quarter investor letter for its ...

The world's 10 richest families

For our list, we exclude families where the wealth is first generation. For example, while Tesla CEO Elon Musk is the world's ...
24/7 Wall St. on MSN

3 Dave Ramsey strategies smart investors pay attention to

Dave Ramsey can be what many individuals would call a controversial figure. His decades of experience in counseling ...

Should Investors Stick to Warren Buffett's 70/30 Rule in 2026?

Given that Warren Buffett is one of the greatest, if not the very best, investors of all time, it's understandable that the market closely follows his stock picks and is always cu ...

EU says 'seriously looking' into Musk's Grok AI over sexual deepfakes of minors

The European Commission said Monday it is "very seriously looking" into complaints that Elon Musk's AI tool Grok is being ...

Halozyme Therapeutics, Inc.: Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE for Obesity

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme ...